Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

Sigal Fishman; Yoav Lurie; Hava Peretz; Tova Morad; Elisheva Grynberg; Laurie M Blendis; Moshe Leshno; Eli Brazowski; Guy Rosner; Zamir Halpern

doi:10.1111/j.1478-3231.2005.01236.x

Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

Identifier:nobleid.org/w1/20260515/CAA55FF9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CAA55FF9.svg?ark=w1%2F20260515%2FCAA55FF9)](https://nobleid.org/work/w1/20260515/CAA55FF9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

Identifier:nobleid.org/w1/20260515/CAA55FF9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CAA55FF9.svg?ark=w1%2F20260515%2FCAA55FF9)](https://nobleid.org/work/w1/20260515/CAA55FF9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work